InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Ohri Manu. Insider active across 2 companies, notably GT Biopharma, Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. History available since 15 July 2022. The latest transaction was disclosed on 15 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Ohri Manu is a Director at Axil Brands, Inc. and CFO & Secretary at GT Biopharma, Inc. The declarant has 6 filings in total, and across the sampled recent filings, the period runs from 2022-07-19 to 2026-03-04, with buy volume of EUR 22894 and sell volume of EUR 0. The main transaction nature indicated is Attribution.